Table 1 Patient characteristics and baseline data.
Characteristic | Dexmedetomidine group | Control group | Z or χ2 | P value |
|---|---|---|---|---|
Total patients, no. | 54 | 52 | NA | NA |
Age, mean (SD), year | 46.89 (3.71) | 46.71 (3.66) | 0.248 | 0.805 |
BMI, mean (SD) | 26.59 (2.13) | 26.02 (2.19) | 1.374 | 0.172 |
ASA classification (n, %) | 1.608& | 0.301 | ||
I | 44 (81.5) | 38 (73.1) | ||
II | 10 (18.5) | 14 (26.9) | ||
Time, mean (SD), min | ||||
Surgical | 76.83 (19.25) | 74.13 (20.17) | 0.705 | 0.482 |
Anesthetic | 83.69 (20.84) | 80.71 (21.90) | 0.716 | 0.475 |
Hypertension (Y/N) | 21/43 | 26/26 | 1.325& | 0.250 |
Mellitus (Y/N) | 12/42 | 12/40 | 0.011& | 0.916 |
Use of vasoactive drugs (n, %) | 6 (11.1) | 9 (17.3) | 0.837& | 0.360 |
Tramadol (IQR), mg | 0 (0–100) | 0 (0–100) | − 1.310 | 0.190 |
Bleeding, ml# | 57.79 (9.66) | 57.28 (8.90) | 0.282 | 0.778 |
Crystalloid solution, ml# | 1087.41 (157.35) | 1069.23 (146.08) | 0.616 | 0.539 |
Urine output, ml# | 365.74 (50.31) | 363.46 (47.61) | 0.239 | 0.812 |
